|Download document||Concept paper on good genomics biomarker practices|
|Status||draft: consultation open|
|Consultation start date||04/08/2014|
|Consultation end date||04/11/2014|
|Email address for email@example.com|
Genomic data have become important to evaluate efficacy and safety of a drug for regulatory approval. As a result, genomic information has been increasingly included in drug labels relevant for the benefit/risk evaluation of a drug and consequently as guidance for patient treatment.